← Back to patent-cliff list
CAS 27806-88-8
Methyl N-(2,6-dichlorophenyl)carbamimidothioate hydrogen iodide
Codes: (III)122568-1-a
Application context (from source-drug indications)
Attention deficit hyperactivity disorderClonidine Hydrochloride (Tris Pharma)HypertensionClonidine Hydrochloride (Tris Pharma)
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Clonidine Hydrochloride (Tris Pharma) | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,6-Dichloroaniline→(2,6-dichlorophenyl)thiourea→N-[(2,6-Dichlorophenyl)carbamothioyl]benzamide→Methyl N-(2,6-dichlorophenyl)carbamimidothioate hydrogen iodide→1,2-Diaminoethane
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.